knowledge -WSS

knowledge

author：entertainment 2025-10-01 14:19:54 - browse：5821

Eli Lilly headquarters in Indianapolis – pharmaceutical coverage from STAT — Darron Cummings/AP

LONDON — A U.K. government agency on Tuesday said that it won’t recommend Eli Lilly’s Mounjaro — part of a new class of medications that help patients lose weight — for people with type 2 diabetes without additional evidence.

Mounjaro, also known as tirzepatide, has U.S. approval for type 2 diabetes and is expected to win the regulatory green light for obesity later this year. It is one of several medications, along with Wegovy and Ozempic from Novo Nordisk, that have shown dramatic weight loss results, creating a surge in demand and blockbuster sales expectations.

But in draft guidance, the U.K.’s National Institute for Health and Care Excellence, which assesses the cost-effectiveness of medications, said it had asked Lilly for more data “to address the uncertainties in the clinical evidence, when compared to all relevant alternative treatments.” NICE recommendations are used by the National Health Service to determine whether to provide certain medications.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Affirmative action in medical school literally saved lives
Next article： What we know about the American soldier detained in North Korea

WSS

UK homeowners get some respite as inflation falls by more than anticipated to a 15

Israeli protesters block highways, train stations as Netanyahu moves ahead with judicial overhaul

Humana’s losses in Medicare Advantage tank its stock

Zyn nicotine pouches become unlikely player in latest culture war

10 reasons why health care startups fail

10 reasons why health care startups fail

leisure time

knowledge

Wikipedia

DIEP, the 'gold standard' of breast reconstruction, is under threat

15 die by electrocution after transformer explodes in northern India

The high cost of giving birth even with insurance

FDA seeking to stop procedures at two unregulated stem cell clinics

Virginia high school admissions case could be legal follow

The Affordable Care Act has saved billions in health care costs

23andMe had bad news about my health. I wish a person had delivered it

ER docs worry over extreme heat as a 'mass casualty event'

Jerome Adams on the need for new antivirals for Covid

Vertex non

focus

Merck CEO won’t testify in Senate, citing no expertise in drug prices

A look at other Americans who have crossed into North Korea over the years

Flagship, Pfizer team up in deal worth up to $7 billion

Health Care Service Corp to buy Cigna Medicare Advantage plans

Readout Newsletter: The latest on Novavax, Merck, Bluebird

Manchin plays down potential 3rd

focus

hotspot

hotspot

entertainment